Cargando…
Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
Autores principales: | Prokopez, Cintia R., Farinola, Romina, Vallejos, Miguel, Lopredo, Lorena S., Sfriso, Luciano E., Chiapella, Luciana C., Arce, Claudio, Corral, Ricardo M., Cuesta, Manuel J., Alomo, Martín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784573/ https://www.ncbi.nlm.nih.gov/pubmed/35123336 http://dx.doi.org/10.1016/j.schres.2022.01.035 |
Ejemplares similares
-
An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses
por: Prokopez, Cintia R., et al.
Publicado: (2021) -
T184. THE ROLE OF ADVERSE CHILDHOOD EXPERIENCES IN THE DEVELOPMENT OF A MORE SEVERE TYPE OF SCHIZOPHRENIA
por: Prokopez, Cintia, et al.
Publicado: (2020) -
Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
por: Johnsen, Erik, et al.
Publicado: (2010) -
A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine
por: Nagaraj, Anil Kumar M., et al.
Publicado: (2009) -
Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial
por: Kjelby, Eirik, et al.
Publicado: (2011)